Hardman & Co: Shield Therapeutics (STX): Cash management is key
Hardman & Co Research Hardman & Co: Shield Therapeutics (STX): Cash management is key 23-May-2024 / 07:15 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman